Featured Research

from universities, journals, and other organizations

Red Cell Substitute Shows Promise As Treatment For Sickle Cell Disease

Date:
July 31, 2007
Source:
American Society of Anesthesiologists
Summary:
Studies in mice suggest that a red blood cell substitute based on human hemoglobin could be a promising new treatment for sickle cell disease in humans. Researchers report on experiments in mice genetically engineered to produce a condition similar to human sickle cell disease--an inherited disorder in which the red blood cells have an abnormal sickled or crescent-moon shape. Especially during attacks called "sickle cell crises," the sickle cells obstruct small blood vessels, blocking blood flow to organs and other parts of the body and thereby depriving the body's tissues of oxygen.

Studies in mice suggest that a red blood cell substitute based on human hemoglobin could be a promising new treatment for sickle cell disease in humans.

The August issue of the journal Anesthesiology features a study showing that a newly developed "hemoglobin-based oxygen carrier" (HBOC) called HRC 101 (Hemosol, Mississauga, Ontario, Canada) dramatically improves survival in mice with "sickled" red blood cells exposed to low-oxygen conditions. "HRC 101 warrants further evaluation as a therapeutic modality in sickle cell disease," concludes the study, led by Dr. Mark W. Crawford of The Hospital for Sick Children, University of Toronto.

Dr. Crawford and colleagues report on experiments in mice genetically engineered to produce a condition similar to human sickle cell disease—an inherited disorder in which the red blood cells have an abnormal sickled or crescent-moon shape. Especially during attacks called "sickle cell crises," the sickle cells obstruct small blood vessels, blocking blood flow to organs and other parts of the body and thereby depriving the body’s tissues of oxygen.

The researchers compared the effects of low oxygen conditions—intended to mimic sickle cell crisis—in sickle-cell versus normal mice (all animals were under anesthesia [asleep] during the procedure). Some mice received HRC 101 to see if the red cell substitute could protect organs against the damaging effects of obstructed blood flow, while others, in control groups, received a placebo.

All of the normal mice tolerated a one-hour period of low oxygen. By comparison, untreated sickle-cell mice did not tolerate the low-oxygen condition.

In contrast, more sickle-cell mice that received the artificial oxygen carrier tolerated the one-hour period of decreased oxygen. HRC 101 allowed the sickle-cell mice to tolerate the low-oxygen environment about five times longer.

Patients with sickle cell disease need frequent blood transfusions to treat anemia and other complications. Although transfusions are beneficial, they have several short- and long-term risks.

"Hemoglobin-based oxygen carriers are red cell substitutes that can be used to increase oxygen-carrying capacity and intravascular volume," according to the authors. HRC 101 may be useful in the management of sickle cell disease because of its potential to bypass the obstruction caused by sickled cells and allow more oxygen to reach the organs and tissues. HRC 101, like some other HBOCs, also has other important advantages over blood transfusions—it can be stored for long periods and doesn’t require a matched blood donor.

The results "are consistent with the hypothesis that HRC 101 augments oxygen delivery to the microcirculation," the researchers write—possibly by increasing the oxygen-carrying capacity of the blood, reducing red cell sickling, and/or bypassing occluded blood flow. Although much more research is needed before human trials can be designed, HBOCs may one day provide a new approach to treatment for patients with sickle cell disease.

While a number of studies of anesthetic drugs in animals have provided useful direction for further research, it is important to note that animal studies are considered basic science and their findings do not always translate to the complex physiological system of human beings.

For additional information on this study, go to:


Story Source:

The above story is based on materials provided by American Society of Anesthesiologists. Note: Materials may be edited for content and length.


Cite This Page:

American Society of Anesthesiologists. "Red Cell Substitute Shows Promise As Treatment For Sickle Cell Disease." ScienceDaily. ScienceDaily, 31 July 2007. <www.sciencedaily.com/releases/2007/07/070727213422.htm>.
American Society of Anesthesiologists. (2007, July 31). Red Cell Substitute Shows Promise As Treatment For Sickle Cell Disease. ScienceDaily. Retrieved April 20, 2014 from www.sciencedaily.com/releases/2007/07/070727213422.htm
American Society of Anesthesiologists. "Red Cell Substitute Shows Promise As Treatment For Sickle Cell Disease." ScienceDaily. www.sciencedaily.com/releases/2007/07/070727213422.htm (accessed April 20, 2014).

Share This



More Health & Medicine News

Sunday, April 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Nine-Month-Old Baby Can't Open His Mouth

Nine-Month-Old Baby Can't Open His Mouth

Newsy (Apr. 19, 2014) Nine-month-old Wyatt Scott was born with a rare disorder called congenital trismus, which prevents him from opening his mouth. Video provided by Newsy
Powered by NewsLook.com
'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins